Genomic Health, Inc. (NASDAQ: GHDX) is a provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
Frequently Asked Questions
What is Market Cap of Genomic Health Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Genomic Health Inc market cap is N/A.
What is the 52-week high for Genomic Health Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Genomic Health Inc 52 week high is N/A as of September 12, 2025.
What is the 52-week low for Genomic Health Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Genomic Health Inc 52 week low is N/A as of September 12, 2025.
What was Genomic Health Inc stock price yesterday?
Genomic Health Inc stock price yesterday was $63.44.
What is the PE ratio of Genomic Health Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Genomic Health Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Genomic Health Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Genomic Health Inc P/B ratio is None.
What is Genomic Health Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Genomic Health Inc's EBITDA is 35.26.
What is the 50-day moving average of Genomic Health Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Genomic Health Inc 50-day moving average is N/A.
